Telemedicine and decentralized models of care: from anticoagulant monitoring to an expanded concept of vascular medicine.

Sophie Testa, Adriano Alatri, Oriana Paoletti, Giampietro Morstabilini, Maria Anunzia Medagliani, Nadia Denti, Emanuela Martellenghi, Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results. Internal and Emergency Medicine. ,vol. 1, pp. 24- 29 ,(2006) , 10.1007/BF02934716

Deborah A. Cios, William L. Baker, Stephen D. Sander, Olivia J. Phung, Craig I. Coleman, Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis. American Journal of Health-system Pharmacy. ,vol. 66, pp. 916- 925 ,(2009) , 10.2146/AJHP080507

Geoffrey D. Barnes, Eva Kline-Rogers, Engaging with quality improvement in anticoagulation management Journal of Thrombosis and Thrombolysis. ,vol. 39, pp. 403- 409 ,(2015) , 10.1007/S11239-015-1184-8

Nick van Es, Michiel Coppens, Sam Schulman, Saskia Middeldorp, Harry R. Büller, Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood. ,vol. 124, pp. 1968- 1975 ,(2014) , 10.1182/BLOOD-2014-04-571232

Sophie Testa, Oriana Paoletti, Anke Zimmermann, Laura Bassi, Silvia Zambelli, Emilia Cancellieri, The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants Thrombosis. ,vol. 2012, pp. 835356- 835356 ,(2012) , 10.1155/2012/835356

Walter Ageno, Lorenzo G Mantovani, Sylvia Haas, Reinhold Kreutz, Danja Monje, Jonas Schneider, Martin van Eickels, Martin Gebel, Elizabeth Zell, Alexander G G Turpie, Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study The Lancet Haematology. ,vol. 3, ,(2016) , 10.1016/S2352-3026(15)00257-4

Geoffrey D. Barnes, Brahmajee K. Nallamothu, Anne E. Sales, James B. Froehlich, Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants Circulation: Cardiovascular Quality and Outcomes. ,vol. 9, pp. 182- 185 ,(2016) , 10.1161/CIRCOUTCOMES.115.002366

Gualtiero Palareti, , Emilia Antonucci, Ludovica Migliaccio, Nicoletta Erba, Francesco Marongiu, Vittorio Pengo, Daniela Poli, Sophie Testa, Alberto Tosetto, Armando Tripodi, Marco Moia, Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago. Internal and Emergency Medicine. ,vol. 12, pp. 1109- 1119 ,(2017) , 10.1007/S11739-017-1678-9

George Ntaios, Vasileios Papavasileiou, Konstantinos Makaritsis, Konstantinos Vemmos, Patrik Michel, Gregory Y.H. Lip, Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Stroke. ,vol. 48, pp. 2494- 2503 ,(2017) , 10.1161/STROKEAHA.117.017549

Emanuel Raschi, Matteo Bianchin, Cecilia Fantoni, Walter Ageno, Fabrizio De Ponti, Roberto De Ponti, Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon? Internal and Emergency Medicine. ,vol. 12, pp. 923- 934 ,(2017) , 10.1007/S11739-017-1724-7